573 related articles for article (PubMed ID: 34773920)
1. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
Chao TF; Joung B; Takahashi Y; Lim TW; Choi EK; Chan YH; Guo Y; Sriratanasathavorn C; Oh S; Okumura K; Lip GYH
Thromb Haemost; 2022 Jan; 122(1):20-47. PubMed ID: 34773920
[TBL] [Abstract][Full Text] [Related]
2. 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.
Chao TF; Joung B; Takahashi Y; Lim TW; Choi EK; Chan YH; Guo Y; Sriratanasathavorn C; Oh S; Okumura K; Lip GYH
J Arrhythm; 2021 Dec; 37(6):1389-1426. PubMed ID: 34887945
[TBL] [Abstract][Full Text] [Related]
3. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.
Chiang CE; Okumura K; Zhang S; Chao TF; Siu CW; Wei Lim T; Saxena A; Takahashi Y; Siong Teo W
J Arrhythm; 2017 Aug; 33(4):345-367. PubMed ID: 28765771
[TBL] [Abstract][Full Text] [Related]
4. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).
Lip GYH; Collet JP; Haude M; Byrne R; Chung EH; Fauchier L; Halvorsen S; Lau D; Lopez-Cabanillas N; Lettino M; Marin F; Obel I; Rubboli A; Storey RF; Valgimigli M; Huber K;
Europace; 2019 Feb; 21(2):192-193. PubMed ID: 30052888
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
6. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
[TBL] [Abstract][Full Text] [Related]
7. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Haeusler KG; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
Eur Heart J; 2018 Apr; 39(16):1330-1393. PubMed ID: 29562325
[TBL] [Abstract][Full Text] [Related]
8. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.
Chiang CE; Wu TJ; Ueng KC; Chao TF; Chang KC; Wang CC; Lin YJ; Yin WH; Kuo JY; Lin WS; Tsai CT; Liu YB; Lee KT; Lin LJ; Lin LY; Wang KL; Chen YJ; Chen MC; Cheng CC; Wen MS; Chen WJ; Chen JH; Lai WT; Chiou CW; Lin JL; Yeh SJ; Chen SA
J Formos Med Assoc; 2016 Nov; 115(11):893-952. PubMed ID: 27890386
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
[TBL] [Abstract][Full Text] [Related]
10. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.
Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Georg Haeusler K; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
Europace; 2018 Aug; 20(8):1231-1242. PubMed ID: 29562331
[TBL] [Abstract][Full Text] [Related]
11. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
Skanes AC; Healey JS; Cairns JA; Dorian P; Gillis AM; McMurtry MS; Mitchell LB; Verma A; Nattel S;
Can J Cardiol; 2012; 28(2):125-36. PubMed ID: 22433576
[TBL] [Abstract][Full Text] [Related]
12. Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey.
Larsen TB; Potpara T; Dagres N; Proclemer A; Sciarrafia E; Blomström-Lundqvist C;
Europace; 2015 May; 17(5):819-24. PubMed ID: 25926476
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients.
Schäfer A; Flierl U; Berliner D; Bauersachs J
Cardiovasc Drugs Ther; 2020 Aug; 34(4):555-568. PubMed ID: 32350792
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry.
Tse HF; Teo WS; Siu CW; Chao TF; Park HW; Shimizu W; Wong YK; Lip GYH
Europace; 2022 Dec; 24(12):1889-1898. PubMed ID: 35025986
[TBL] [Abstract][Full Text] [Related]
15. "As Needed" nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study.
Zado ES; Pammer M; Parham T; Lin D; Frankel DS; Dixit S; Marchlinski FE
J Cardiovasc Electrophysiol; 2019 May; 30(5):631-638. PubMed ID: 30706975
[TBL] [Abstract][Full Text] [Related]
16. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.
Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Eur Heart J; 2013 Jul; 34(27):2094-106. PubMed ID: 23625209
[TBL] [Abstract][Full Text] [Related]
17. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
Lip GY; Bongiorni MG; Dobreanu D; Lewalter T; Hastrup Svendsen J; Blomström-Lundqvist C;
Europace; 2013 Oct; 15(10):1526-32. PubMed ID: 24072770
[TBL] [Abstract][Full Text] [Related]
18. A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation.
Mai L; Wu Y; Luo J; Liu X; Zhu H; Zheng H; Liang G; Zhang Y; Huang Y
BMJ Open; 2019 Sep; 9(9):e031180. PubMed ID: 31530618
[TBL] [Abstract][Full Text] [Related]
19. 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.
Macle L; Cairns J; Leblanc K; Tsang T; Skanes A; Cox JL; Healey JS; Bell A; Pilote L; Andrade JG; Mitchell LB; Atzema C; Gladstone D; Sharma M; Verma S; Connolly S; Dorian P; Parkash R; Talajic M; Nattel S; Verma A;
Can J Cardiol; 2016 Oct; 32(10):1170-1185. PubMed ID: 27609430
[TBL] [Abstract][Full Text] [Related]
20. Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry.
Boriani G; Proietti M; Laroche C; Fauchier L; Marin F; Nabauer M; Potpara T; Dan GA; Kalarus Z; Diemberger I; Tavazzi L; Maggioni AP; Lip GYH; ;
Europace; 2018 May; 20(5):747-757. PubMed ID: 29016832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
